
A sold-out crowd is set to pack the Tuscany Suites and Casino on Thursday for the seventh annual Substance Misuse and Overdose Prevention Summit, a gathering built around the theme “The Science of Hope” that arrives at a tense moment for Southern Nevada's fight against overdose deaths. Organizers say interest outpaced capacity, and a waitlist has opened for anyone still hoping to get in.
The Southern Nevada Health District is hosting the event alongside the PACT Coalition, the Nevada High Intensity Drug Trafficking Area program, and the Nevada Institute for Children's Research & Policy, according to Southern Nevada Health District. The health district notes the day's programming includes a panel marking the 10th anniversary of the Southern Nevada Opioid Advisory Council, the group founded in 2016 to coordinate regional response across four pillars: prevention, rescue, treatment, and recovery, as reported by the Las Vegas Sun. Local organizations including the PACT Coalition, Foundation for Recovery, and U.S. VETS Las Vegas are participating, according to FOX5 Las Vegas.
Keynote speaker Mary Jadwisiak, founder and CEO of the behavioral health consulting group Holding the Hope, will headline the summit, per the health district's release. Her organization focuses on peer support and training rooted in lived recovery experience, a model that has become central to how Southern Nevada approaches addiction treatment.
Sessions Target Emerging Drugs and Mental Health Gaps
The summit's agenda includes sessions on overdose response, emerging drug trends, and connecting mental health care with addiction treatment, according to the FOX5 Las Vegas report. That programming follows a scare earlier this year: in February, Southern Nevada Health District officials issued a public health warning after medetomidine — a potent veterinary sedative nicknamed “Rhino Tranq” — turned up in the local illicit drug supply, a substance that causes deep sedation unaffected by naloxone, Hoodline previously reported.
The stakes behind this year's summit are sharper than usual. Clark County Coroner's Office figures show local drug fatalities fell to 1,228 in 2025, down from 1,389 in 2024, Hoodline reported in May. But that modest improvement masks a wider problem: a CDC Epi-Aid investigation conducted with local health officials in 2026 found that while overdose deaths nationally dropped roughly 15.9%, Nevada's decline was just 2.2%, according to Hoodline's earlier coverage of the CDC probe into Nevada's stalled progress. That gap has pushed researchers to dig into local drivers like housing instability and unpredictable drug contamination.
Polysubstance Use and Harm Reduction Efforts Loom Large
Public health data underscore why officials are worried about what's mixed into the local drug supply. A report by the Nevada Division of Public and Behavioral Health found that overdose deaths among Clark County residents involving fentanyl combined with stimulants like methamphetamine or cocaine rose 97% between 2020 and 2023 — a trend that raises fatal overdose risk especially among people who don't regularly use opioids.
On the harm-reduction side, regional outreach programs distributed more than 200,000 doses of naloxone in 2025 to prevent fatal opioid overdoses, Southern Nevada Health District officials have reported. Nevada also tracks overdose trends in near real time through the CDC-funded Overdose Data to Action initiative, which compiles monthly surveillance on non-fatal emergency department visits to help guide where resources go, according to the Nevada Opioid Center of Excellence.
Tougher Trafficking Laws Add Enforcement Pressure
Law enforcement has also sharpened its tools against major suppliers. Nevada lawmakers passed Senate Bill 35 in June 2023, lowering the drug weight threshold for high-level fentanyl trafficking charges to 28 grams or more, with the law taking effect that October, Hoodline has reported. That statute was invoked earlier this month when federal authorities charged seven people after seizing 40 kilograms of fentanyl and guns in Las Vegas, a case Hoodline covered as part of its ongoing look at the region's drug supply enforcement.
Thursday's summit reflects a decade of work by the Southern Nevada Opioid Advisory Council to knit together public health, law enforcement, and academic researchers under one strategy. With the event sold out and a waitlist forming, organizers appear to be betting that demand for solutions in Southern Nevada is only growing.









